Skip to main content
Public health

Guidance and regulation

Skip to results
3,371 results sorted by Most viewed
  • An easy to read leaflet explaining diabetic eye screening (DES).

  • An overview of the legal requirements for children’s medicines that Marketing Authorisation Holders (MAHs) need to abide by.

  • Guidance, resources and information for professionals about streptococcal infections.

  • UK National Screening Committee (UK NSC) criteria for appraising the viability, effectiveness and appropriateness of a screening programme.

  • An overview of the National Chlamydia Screening Programme (NCSP).

  • Information about what personal information is used by the screening programmes and why. Includes your options, rights and how to find out more.

  • Patient group direction (PGD) template to support the provision of hepatitis B vaccine to renal patients.

  • Training and continuing professional development (CPD) for people working in the NHS bowel cancer screening programme (BCSP) in England.

  • Explains how commissioners and health professionals can use data and analysis for decisions about dementia services and interventions.

  • Advice and guidance on the health needs of migrant patients for healthcare practitioners.

  • Advice and guidance on the health needs of migrant patients for healthcare practitioners.

  • Information for health professionals on the characteristics, diagnosis and treatment of Pontiac fever.

  • Sets out the national procedures for auditing cases of invasive cervical cancer.

  • How commissioners and other health professionals can measure, understand and improve the mental wellbeing of children and young people

  • Advice and guidance for healthcare practitioners on the health needs of migrant patients.

  • A toolkit containing guidance, data and other resources to support professionals who are helping families affected by parental alcohol and drug problems.

  • How to use a crossover randomised controlled trial to evaluate your digital health product.

  • Protocol for the administration of COVID-19 mRNA vaccine to individuals aged 5 to 17 years in accordance with the national COVID-19 vaccination programme.

  • This information can help parents of babies with suspected or confirmed diagnosis of severe skeletal dysplasia discuss the condition with healthcare professionals.

  • The fund is now closed for applications. Applicants have been contacted directly regarding the outcome of their application, and details of the funding awarded are published below.